Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Biotech's Wall Street malaise, Valeant's Washington woes, and immuno-oncology's primetime slot
Fierce editors discuss another rough week for biotech stocks, Valeant Pharmaceuticals' doggedness in the face of congressional inquiry, and a curious new trend in pharma advertising.
About This Episode
Biotech's Wall Street malaise, Valeant's Washington woes, and immuno-oncology's primetime slot is an episode from FierceBiotech Radio. Fierce editors discuss another rough week for biotech stocks, Valeant Pharmaceuticals' doggedness in the...
Podcast
This episode belongs to FierceBiotech Radio.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Oct 8, 2015, 26:30 long, audio available.
Related Episodes
Continue listening to more episodes from FierceBiotech Radio.
